Cita APA

Nakaoka, Y., Isobe, M., Takei, S., Tanaka, Y., Ishii, T., Yokota, S., . . . Nishimoto, N. (2018). Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: Results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis.

Chicago Style Citation

Nakaoka, Yoshikazu, Mitsuaki Isobe, Syuji Takei, Yoshiya Tanaka, Tomonori Ishii, Shumpei Yokota, Akira Nomura, Seitaro Yoshida, i Norihiro Nishimoto. "Efficacy and Safety of Tocilizumab in Patients With Refractory Takayasu Arteritis: Results From a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial in Japan (the TAKT Study)." Ann Rheum Dis 2018.

Cita MLA

Nakaoka, Yoshikazu, et al. "Efficacy and Safety of Tocilizumab in Patients With Refractory Takayasu Arteritis: Results From a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial in Japan (the TAKT Study)." Ann Rheum Dis 2018.